Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is Needed.

Saved in:
Bibliographic Details
Title: Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is Needed.
Authors: Baker JG; Cell Signalling, School of Life Sciences, C Floor Medical School, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK.; Respiratory Medicine, Queen's Medical Centre, Nottingham University Hospitals, Nottingham NG7 2UH, UK., Sloan EK; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Science, Monash University, Parkville Victoria 3052, Australia., Pfleger KDG; Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Nedlands, Western Australia 6009, Australia., McCormick PJ; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GE, UK., Salmerón C; Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA., Insel PA; Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.; Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Source: Function (Oxford, England) [Function (Oxf)] 2025 Feb 12; Vol. 6 (1).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101770668 Publication Model: Print Cited Medium: Internet ISSN: 2633-8823 (Electronic) Linking ISSN: 26338823 NLM ISO Abbreviation: Function (Oxf) Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2633-8823
DOI:10.1093/function/zqae050